SB 6424: Opioid analgesic drugs
Prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician.
Summary
- Prohibits pharmacists, under certain circumstances, from interchanging or substituting an opioid analgesic drug, brand, or generic for an opioid analgesic drug incorporating a tamper resistance technology.
From the Bill Digest (SB 6424), written by the Legislature's nonpartisan staff. Read the full report ↗
- IntroducedJan 23, 2012
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Adam Kline (D-37)
- Introduced
- January 23, 2012 in the Senate
- Last action
- April 11, 2012
- Companion bill
- HB 2495
AN ACT Relating to prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician;
Sponsors
Prime sponsor: Adam Kline (D-37)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health & Long-Term Care.
SB 6424 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6424 (2019–20) College bound/room & board
- SB 6424 (2017–18) Electric & nat gas companies
- SB 6424 (2015–16) Agency self-assessments
- SB 6424 (2013–14) Biliteracy seal/HS students
- SB 6424 (2009–10) Local excise tax authorities
- SB 6424 (2007–08) Sm game hunting license fees
- SB 6424 (2005–06) Biodiesel feedstock
- SB 6424 (2003–04) Staffing services taxation